We welcome collaborations in clinical development with companies which have strong science-based pipeline. We have successfully completed and have several on-going clinical trials across ASEAN and Australia. Some of our completed success stories are:
- Global phase 3 trial in diffuse large B-cell lymphoma in Indonesia, Malaysia and Philippines completed in 2017 and published
- Global phase 2 trial in inoperable squamous cell carcinoma of head and neck in Singapore and Thailand, completed in 2012 and published
- Phase 2 trial in Cervical cancer in Indonesia
- Global phase 3 trial in resected squamous cell carcinoma of head and neck in Singapore, Australia, Taiwan, S Korea, Saudia Arabia, Cuba, India, Philippines, Malaysia, Indonesia, S Africa and Thailand, in follow up and planned to complete in 2023
We and our sister companies also provide laboratory services such as BA (Bioavailability) and BE (Bioequivalence) studies, CMO for biologics, and diagnostic services including biomarker.